Genetic predisposition in nonalcoholic fatty liver disease

Clin Mol Hepatol. 2017 Mar;23(1):1-12. doi: 10.3350/cmh.2016.0109. Epub 2017 Mar 9.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has reached global epidemic proportions. Although the disease is relatively benign in the early stages, when severe clinical forms, including nonalcoholic steatohepatitis (NASH), cirrhosis and even hepatocellular carcinoma, occur, they result in worsening the long-term prognosis. A growing body of evidence indicates that NAFLD develops from a complex process in which many factors, including genetic susceptibility and environmental insults, are involved. In this review, we focused on the genetic component of NAFLD, with special emphasis on the role of genetics in the disease pathogenesis and natural history. Insights into the topic of the genetic susceptibility in lean individuals with NAFLD and the potential use of genetic tests in identifying individuals at risk are also discussed.

Keywords: NASH; PNPLA3; TM6SF2; alcoholic liver disease; gene variants.

Publication types

  • Review

MeSH terms

  • Genetic Predisposition to Disease*
  • Humans
  • Lipase / genetics
  • Liver / metabolism
  • Liver / pathology
  • Membrane Proteins / genetics
  • Non-alcoholic Fatty Liver Disease / genetics*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Polymorphism, Single Nucleotide
  • Risk Factors

Substances

  • Membrane Proteins
  • TM6SF2 protein, human
  • Lipase
  • adiponutrin, human